Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Improvac - EU/2/09/095/003 Zoetis Belgium S.A., Beļģija QG03XA91 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Gonadorelin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pfizer Animal Health s.a., Beļģija
Date of authorisation/renewal: 10-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/09/095/003 4 Polietilēna pudele, 250 ml -
LETIFEND - EU/2/16/195/002 Laboratorios LETI, S.L. unipersonal, Spānija QI07A dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Recombinant Protein Q from Leishmania infantum MON-1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 20-Apr-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/16/195/002 4 Stikla flakons, 1 deva -
Cortavance 0.584 mg/ml EU/2/06/069/003 Virbac S.A., Francija QD07AC16 dogs Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, solution
International name (active substance): Hydrocortisone aceponate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 13-Sep-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/06/069/003 0,584 mg/ml 1 ABPE pudele, 31 ml -
Synulox RTU - V/I/22/0013 Zoetis Belgium S.A., Beļģija QJ01CR02 cattle; pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 31-Mar-2022
Marketing authorisation valid until: 30-Mar-2027
Marketing authorisation procedure: I
Package leaflet: [DOCX] 22062023_LI (22-Jun-2023)
Labelling text: See products section
Summary of product characteristics: -

Products

ID Strength Package size Primary packaging Labelling
V/I/22/0013-01 1 Flakons, 100 ml [PDF] [PDF]
V/I/22/0013-02 6 Flakons, 100 ml -
Ingelvac CircoFLEX - EU/2/07/079/003 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AA07 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated recombinant Porcine Circovirus type 2
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 13-Feb-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/07/079/003 1 ABPE pudele, 100 deva -
Poulvac Procerta HVT-IBD-ND - EU/2/24/324/002 Zoetis Belgium S.A., Beļģija QI01AD16 chickens; embryonated chicken eggs Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Turkey herpesvirus, strain HVT-IBD-ND (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus and fusion protein gene of Newcastle disease virus, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 23-Jan-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/24/324/002 1 Stikla ampula, 4000 deva -
Nobilis Rhino CV - V/I/21/0010 Intervet Ireland Ltd, Īrija QI01AD01 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension
International name (active substance): Live attenuated avian rhinotracheitis virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 01-Dec-2025
Marketing authorisation valid until: 30-Nov-2030
Marketing authorisation procedure: I
Package leaflet: [DOCX] 01122025_LI (01-Dec-2025)
Labelling text: See products section
Summary of product characteristics: -

Products

ID Strength Package size Primary packaging Labelling
V/I/21/0010-01 1 10 Stikla flakons, 5000 deva [PDF]
V/I/21/0010-02 1 1 Stikla flakons, 1000 deva [PDF]
V/I/21/0010-03 1 10 Stikla flakons, 1000 deva [PDF]
Rhiniseng - EU/2/10/109/005 Laboratorios Hipra S.A., Spānija QI09AB04 sows; gilt Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Pasteurella multocida Serotype D,Inactivated Bordetella bronchiseptica
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 15-Sep-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/10/109/005 1 Pudele, 20 ml -
Metacam 5 mg/ml EU/2/97/004/011 Boehringer Ingelheim Vetmedica GmbH, Vācija QM01AC06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 06-Dec-2007
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/97/004/011 5 mg/ml 1 Stikla flakons, 20 ml -
Ceperolon 80 mg EU/2/24/321/012 CP-Pharma Handelsgesellschaft GmbH, Vācija QC03DA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: Chewable tablet
International name (active substance): Spironolactone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 12-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/24/321/012 80 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
NexGard Combo - EU/2/20/267/006 Boehringer Ingelheim Vetmedica GmbH, Vācija QP54AA54 cats 2.5-7.5 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Esafoxolaner, Eprinomectin, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Animal Health France SCS., Francija
Date of authorisation/renewal: 06-Jan-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/20/267/006 3 Aplikators, 0,9 ml -
Emdocam 20 mg/ml EU/2/11/128/003 Emdoka bvba, Beļģija QM01AC06 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 21-Jun-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/11/128/003 20 mg/ml 1 Stikla pudelīte, 250 ml -
VeroBlue-3 - EU/2/26/362/001 VEROVACCiNES GmbH, Vācija QI04AA02 sheep Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Bluetongue virus, serotype 3, VP2 protein (recombinant)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet AD, Bulgārija
Date of authorisation/renewal: 23-Apr-2026
Marketing authorisation valid until: 22-Apr-2027
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/26/362/001 1 Stikla flakons, 5 deva;Stikla flakons (šķīdinātājs), 5 ml -
Purevax RCP FeLV - EU/2/04/048/001 Boehringer Ingelheim Vetmedica GmbH, Vācija QI06AJ03 cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Recombinant Canarypox virus,Attenuated feline rhinotracheitis herpesvirus,Inactivated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Merial Laboratory of Lyon Porte des Alpes, Francija
Date of authorisation/renewal: 23-Feb-2005
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/04/048/001 1 devas/flakonā 10 Stikla pudelīte, 1 deva -
Emevet - EU/2/25/343/003 CP-Pharma Handelsgesellschaft GmbH, Vācija QA04AD90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Maropitant
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 02-Jun-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/25/343/003 5 Blisteris, 10 tablete -
Nobivac LeuFel - EU/2/17/217/001 VIRBAC, Francija QI06AA01 cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated feline leukaemia virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 17-Oct-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/17/217/001 10 Stikla flakons, 1 ml -
ERYSENG PARVO - EU/2/14/167/001 Laboratorios Hipra S.A., Spānija QI09AL01 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Erysipelothrix rhusiopathiae ,Inactivated swine parvovirus strain
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 05-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/14/167/001 1 Stikla flakons, 10 deva -
Prevomax - EU/2/17/211/003 Dechra Regulatory B.V., Nīderlande QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Eurovet Animal Health B.V., Nīderlande;Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 11-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/17/211/003 1 Stikla flakons, 25 ml -
ReproCyc ParvoFLEX - EU/2/19/237/002 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AA02 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Porcine Parvovirus strain 27a VP2 subunit antigen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 26-Apr-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/237/002 1 ABPE pudele, 100 ml/50 deva -
Rheumocam 5.0 mg/ml EU/2/07/078/017 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QM01AC06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 18-Dec-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/07/078/017 5 mg/ml 1 Stikla flakons, 100 ml -

3082 records